BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 12751263)

  • 21. Approaches to fungal diagnosis in transplantation.
    Patterson TF
    Transpl Infect Dis; 1999 Dec; 1(4):262-72. PubMed ID: 11428997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients.
    Patterson JE; Peters J; Calhoon JH; Levine S; Anzueto A; Al-Abdely H; Sanchez R; Patterson TF; Rech M; Jorgensen JH; Rinaldi MG; Sako E; Johnson S; Speeg V; Halff GA; Trinkle JK
    Transpl Infect Dis; 2000 Mar; 2(1):22-8. PubMed ID: 11429006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overview of systemic fungal infections.
    Rolston K
    Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):11-4. PubMed ID: 11757845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing patterns and trends in systemic fungal infections.
    Richardson MD
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i5-i11. PubMed ID: 16120635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fungal infections in intestinal and multivisceral transplant recipients.
    Florescu DF; Sandkovsky U
    Curr Opin Organ Transplant; 2015 Jun; 20(3):295-302. PubMed ID: 25944228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voriconazole in the treatment of invasive mold infections in transplant recipients.
    Fortún J; Martín-Dávila P; Sánchez MA; Pintado V; Alvarez ME; Sánchez-Sousa A; Moreno S
    Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):408-13. PubMed ID: 12827536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakthrough invasive fungal infections: Who is at risk?
    Jenks JD; Cornely OA; Chen SC; Thompson GR; Hoenigl M
    Mycoses; 2020 Oct; 63(10):1021-1032. PubMed ID: 32744334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive aspergillosis in organ transplant recipients: new issues in epidemiologic characteristics, diagnosis, and management.
    Singh N
    Med Mycol; 2005 May; 43 Suppl 1():S267-70. PubMed ID: 16110819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging fungal pathogens in solid organ transplantation.
    Mishkin A
    Curr Opin Organ Transplant; 2021 Aug; 26(4):440-444. PubMed ID: 34074940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fungal complications of transplantation: diagnosis, treatment and prevention.
    Warnock DW
    J Antimicrob Chemother; 1995 Oct; 36 Suppl B():73-90. PubMed ID: 8601545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of infectious complications in solid-organ transplant recipients.
    Grim SA; Clark NM
    Clin Pharmacol Ther; 2011 Aug; 90(2):333-42. PubMed ID: 21716270
    [No Abstract]   [Full Text] [Related]  

  • 32. Opportunistic fungal pneumonia.
    Connolly JE; McAdams HP; Erasmus JJ; Rosado-de-Christenson ML
    J Thorac Imaging; 1999 Jan; 14(1):51-62. PubMed ID: 9894953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.
    Anesi JA; Baddley JW
    Infect Dis Clin North Am; 2016 Mar; 30(1):277-96. PubMed ID: 26739603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive fungal infections in renal transplant recipients: about 11 cases.
    Trabelsi H; Néji S; Sellami H; Yaich S; Cheikhrouhou F; Guidara R; Charffedine K; Makni F; Hachicha J; Ayadi A
    J Mycol Med; 2013 Dec; 23(4):255-60. PubMed ID: 24060353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progress and current problems in management of invasive fungal infections in patients with neoplastic diseases.
    Walsh TJ; Lee JW; Roilides E; Pizzo PA
    Curr Opin Oncol; 1992 Aug; 4(4):647-55. PubMed ID: 1511021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protists as opportunistic pathogens: public health impact in the 1990s and beyond.
    Kaplan JE; Jones JL; Dykewicz CA
    J Eukaryot Microbiol; 2000; 47(1):15-20. PubMed ID: 10651290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive fungal infections in pediatric heart transplant recipients: incidence, risk factors, and outcomes.
    Zaoutis TE; Webber S; Naftel DC; Chrisant MA; Kaufman B; Pearce FB; Spicer R; Dipchand AI;
    Pediatr Transplant; 2011 Aug; 15(5):465-9. PubMed ID: 21108712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fungal infections in solid organ recipients.
    Badiee P; Kordbacheh P; Alborzi A; Zeini F; Mirhendy H; Mahmoody M
    Exp Clin Transplant; 2005 Dec; 3(2):385-9. PubMed ID: 16417449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Frequency of detection of soluble antigens of Candida spp. and Aspergillus spp. using serological assays in body fluids of patients of Central Clinical Hospital in Warsaw].
    Jarzynka S; Przybylski M; Sulowska A; Golaś M; Dzieciątkowski T; Wróblewska M
    Med Dosw Mikrobiol; 2016; 68(3-4):203-212. PubMed ID: 30376620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current status of invasive fungal infections. New diagnostic techniques and antifungal agents].
    Gurguí M; Cuenca-Estrella M
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():1-6. PubMed ID: 19572428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.